...
amgn-img

Amgen Inc, Common Stock

AMGN

NSQ

$258.78

-$7.17

(-2.7%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$143.25B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
33.9923
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.97M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
3.57%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.60
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$255.01 L
$341.72 H
$258.78

About Amgen Inc, Common Stock

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameAMGNSectorS&P500
1-Week Return-5.35%-2.06%-0.55%
1-Month Return-7.17%-1.92%2.72%
3-Month Return-22.27%-10.4%7.66%
6-Month Return-15.43%-4.6%10.15%
1-Year Return-6.06%4.06%27.53%
3-Year Return17.63%1.94%32.31%
5-Year Return6.96%36.48%89.2%
10-Year Return53.6%97.46%194.59%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue23.36B25.42B25.98B26.32B28.19B[{"date":"2019-12-31","value":82.87,"profit":true},{"date":"2020-12-31","value":90.19,"profit":true},{"date":"2021-12-31","value":92.16,"profit":true},{"date":"2022-12-31","value":93.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue4.36B6.16B6.45B6.41B8.45B[{"date":"2019-12-31","value":51.54,"profit":true},{"date":"2020-12-31","value":72.88,"profit":true},{"date":"2021-12-31","value":76.37,"profit":true},{"date":"2022-12-31","value":75.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit19.01B19.27B19.52B19.92B19.74B[{"date":"2019-12-31","value":95.43,"profit":true},{"date":"2020-12-31","value":96.73,"profit":true},{"date":"2021-12-31","value":98.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.11,"profit":true}]
Gross Margin81.35%75.77%75.16%75.66%70.02%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":93.14,"profit":true},{"date":"2021-12-31","value":92.38,"profit":true},{"date":"2022-12-31","value":93.01,"profit":true},{"date":"2023-12-31","value":86.07,"profit":true}]
Operating Expenses9.33B10.13B10.38B10.35B11.84B[{"date":"2019-12-31","value":78.8,"profit":true},{"date":"2020-12-31","value":85.51,"profit":true},{"date":"2021-12-31","value":87.66,"profit":true},{"date":"2022-12-31","value":87.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income9.67B5.79B6.00B5.33B7.90B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":59.89,"profit":true},{"date":"2021-12-31","value":62.07,"profit":true},{"date":"2022-12-31","value":55.15,"profit":true},{"date":"2023-12-31","value":81.63,"profit":true}]
Total Non-Operating Income/Expense(1.07B)(2.01B)(501.00M)605.00M(2.51B)[{"date":"2019-12-31","value":-177.19,"profit":false},{"date":"2020-12-31","value":-332.56,"profit":false},{"date":"2021-12-31","value":-82.81,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-415.04,"profit":false}]
Pre-Tax Income9.14B8.13B6.70B7.35B7.86B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":89,"profit":true},{"date":"2021-12-31","value":73.33,"profit":true},{"date":"2022-12-31","value":80.39,"profit":true},{"date":"2023-12-31","value":85.96,"profit":true}]
Income Taxes1.30B869.00M808.00M794.00M1.14B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":67.05,"profit":true},{"date":"2021-12-31","value":62.35,"profit":true},{"date":"2022-12-31","value":61.27,"profit":true},{"date":"2023-12-31","value":87.81,"profit":true}]
Income After Taxes7.84B7.26B5.89B6.55B6.72B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.63,"profit":true},{"date":"2021-12-31","value":75.15,"profit":true},{"date":"2022-12-31","value":83.55,"profit":true},{"date":"2023-12-31","value":85.65,"profit":true}]
Income From Continuous Operations7.84B7.26B5.89B6.55B7.57B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.63,"profit":true},{"date":"2021-12-31","value":75.15,"profit":true},{"date":"2022-12-31","value":83.55,"profit":true},{"date":"2023-12-31","value":96.48,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income7.84B7.26B5.89B6.55B6.72B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.63,"profit":true},{"date":"2021-12-31","value":75.15,"profit":true},{"date":"2022-12-31","value":83.55,"profit":true},{"date":"2023-12-31","value":85.65,"profit":true}]
EPS (Diluted)14.8316.6017.1117.6918.65[{"date":"2019-12-31","value":79.52,"profit":true},{"date":"2020-12-31","value":89.01,"profit":true},{"date":"2021-12-31","value":91.74,"profit":true},{"date":"2022-12-31","value":94.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AMGN
Cash Ratio 0.44
Current Ratio 1.32
Quick Ratio 0.96

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AMGN
ROA (LTM) 4.60%
ROE (LTM) 55.72%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AMGN
Debt Ratio Lower is generally better. Negative is bad. 0.92
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.08

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AMGN
Trailing PE 33.99
Forward PE 12.90
P/S (TTM) 4.40
P/B 19.03
Price/FCF 43
EV/R 5.98
EV/Ebitda 14.44
PEG 1.91

FAQs

What is Amgen Inc share price today?

Amgen Inc (AMGN) share price today is $258.78

Can Indians buy Amgen Inc shares?

Yes, Indians can buy shares of Amgen Inc (AMGN) on Vested. To buy Amgen Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AMGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Amgen Inc be purchased?

Yes, you can purchase fractional shares of Amgen Inc (AMGN) via the Vested app. You can start investing in Amgen Inc (AMGN) with a minimum investment of $1.

How to invest in Amgen Inc shares from India?

You can invest in shares of Amgen Inc (AMGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in AMGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Amgen Inc shares
What is Amgen Inc 52-week high and low stock price?

The 52-week high price of Amgen Inc (AMGN) is $341.72. The 52-week low price of Amgen Inc (AMGN) is $255.01.

What is Amgen Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Amgen Inc (AMGN) is 33.9923

What is Amgen Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Amgen Inc (AMGN) is 19.03

What is Amgen Inc dividend yield?

The dividend yield of Amgen Inc (AMGN) is 3.57%

What is the Market Cap of Amgen Inc?

The market capitalization of Amgen Inc (AMGN) is $143.25B

What is Amgen Inc’s stock symbol?

The stock symbol (or ticker) of Amgen Inc is AMGN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top